LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation

Product code LON, “System, Test, Automated, Antimicrobial Susceptibility, Short Incubation” in FDA's classification database, is a Class II device type under 21 CFR 866.1645 (fully automated short-term incubation cycle antimicrobial susceptibility system), reviewed by FDA's Microbiology panel. FDA's 510(k) database lists 291 clearances under LON, 94 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LON
Regulation
21 CFR 866.1645
Class
II
Panel
Microbiology
Clearances
291
Most recent
Oct 1, 2026
Median review, last 2 years
90 days
Third-party review
Not eligible
Implant
No

What it covers

A fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases.

The identification in 21 CFR 866.1645, fully automated short-term incubation cycle antimicrobial susceptibility system. FDA gives LON no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K260283VITEK 2 AST-Streptococcus Meropenem (=0.06 - =4 µg/mL)bioMerieux, Inc.Oct 1, 2026Traditional
K260619VITEK 2 AST-Streptococcus Cefepime (<=0.06 – >=4 µg/mL)Biomérieux, Inc.Sep 28, 2026Traditional
K260282VITEK 2 AST-Streptococcus Inducible Clindamycin ResistancebioMerieux, Inc.Apr 15, 2026Traditional
K260281VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)BIOMERIEUXMar 26, 2026Traditional
K251579VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)bioMerieux, Inc.Aug 21, 2025Traditional
K251713BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)Becton, Dickinson and CompanyAug 8, 2025Traditional
K250447BD Phoenix™ Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL)Becton, Dickinson and CompanyMay 19, 2025Traditional
K234012VITEK COMPACT PRObioMerieux, Inc.Mar 14, 2025Traditional
K250344BD Phoenix™ Automated Microbiology SystemBecton, Dickinson and CompanyMar 6, 2025Special
K233986BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL)Becton, Dickinson and CompanyMar 15, 2024Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 291 with a free account)

Clearances by year

94 LON 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)4146
2025590
2024286
202311210
20228189
20215268
2020581
2019884
2018488
20171089
20163242
2014490
20137115
201210200
2011885

Who submits

10 applicants cleared a LON device since 2011. 98% of the clearances went to applicants in United States, then Italy (2%). By type: Traditional 98% and Special 2%.

ApplicantClearances since 2011
bioMerieux, Inc.68
Becton, Dickinson and Company14
Becton, Dickinson & CO2
Biomérieux, Inc.2
Copan Wasp Srl2
Selux Diagnostics, Inc.2
Beckman Coulter, Inc.1
Becton Dickinson & Company1

How FDA classifies it

Class II (special controls). The special control for this device is FDA's guidance document entitled “Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems; Guidance for Industry and FDA.”

From 21 CFR 866.1645. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 866.1645 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LON clearances declared.

Ask about LON

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LON

What is FDA product code LON?

Product code LON, “System, Test, Automated, Antimicrobial Susceptibility, Short Incubation” in FDA's classification database, is a Class II device type under 21 CFR 866.1645 (fully automated short-term incubation cycle antimicrobial susceptibility system), reviewed by FDA's Microbiology panel. FDA's 510(k) database lists 291 clearances under LON, 94 of them since 2011.

How many 510(k) clearances are there under LON?

FDA’s 510(k) database listed 291 clearances under LON as of Oct 29, 2026, 94 of them decided since 2011; the most recent decision was Oct 1, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LON 510(k)?

For the 9 LON clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 90 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LON clearances?

Since 2011: bioMerieux, Inc. (68), Becton, Dickinson and Company (14), Becton, Dickinson & CO (2), Biomérieux, Inc. (2) and Copan Wasp Srl (2). 10 applicants have cleared a LON device in that time.

Sources

  1. FDA product classification: LON · Product Classification database
  2. 21 CFR 866.1645: Fully automated short-term incubation cycle antimicrobial susceptibility system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LON · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LONGet an email when FDA clears, recalls or publishes guidance for LON devices.

Know what FDA already cleared.